January 31, 2012 11:14 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
JP Morgan resumes coverage of Validus (NYSE: VR) with an Overweight rating and a price target of $35 (previously Neutral and $29.50, respectively) on short term opportunity in the stock given momentum in first half of this year. JP Morgan says, "Our rating reflects our belief that the stock offers an attractive 3-6 month trading opportunity for several reasons: 1) VR's core short-tail (re)insurance lines are likely to see bigger headline rate increases into mid-year 2012 than general insurance, especially at April 1. 2) Underlying margins and premium growth should benefit more quickly from rate gains both in absolute terms and relative to our coverage group. 3) Capital management, which was on hold during a 2011 acquisition bid, should resume in 2012."VR closed at #31.78 a share on Monday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.